Sequential metastasis-directed therapy (MDT) for oligometastatic prostate cancer (Oligo PCa) assessed by PET-based imaging

被引：0
|
作者：
Carretero-Gonzalez, Alberto
Kwon, Daniel
Shakhnazaryan, Nonna
Hong, Julian C.
Mohamad, Osama
Feng, Mary Uan-Sian
de Kouchkovsky, Ivan
Borno, Hala
Bose, Rohit
Chou, Jonathan
Desai, Arpita
Fong, Lawrence
Friedlander, Terence W.
Koshkin, Vadim S.
Feng, Felix Y.
Aggarwal, Rahul Raj
Hope, Thomas A.
Small, Eric Jay
机构：
[1] Hosp Univ 12 Octubre, Dept Med Oncol, Madrid, Spain
[2] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA
[5] Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5032
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Metastasis-Directed Therapy for Oligometastatic Castration-Sensitive Prostate Cancer: An Alternative to ADT?
    Cahill, Ellen M. M.
    Pfail, John L. L.
    Fu, Melinda Z. Z.
    Saraiya, Biren
    Mayer, Tina
    Stephenson, Ryan D. D.
    Ennis, Ronald D. D.
    Hathout, Lara
    Deek, Matthew P. P.
    Ghodoussipour, Saum
    Jang, Thomas L. L.
    CURRENT UROLOGY REPORTS, 2023, 24 (07) : 299 - 306
  • [22] The Role of Local Prostate and Metastasis-Directed Radiotherapy in the Treatment of Oligometastatic Prostate Cancer
    Choi, Seo Hee
    Beom, Seung-Hoon
    Choi, Young Deuk
    Ham, Won Sik
    Han, Hyunho
    Han, Woong Kyu
    Jang, Won Sik
    Lee, Seung Hwan
    Cho, Jaeho
    CANCERS, 2024, 16 (18)
  • [23] The Role of Local Prostate and Metastasis-Directed Radiotherapy in the Treatment of Oligometastatic Prostate Cancer
    Choi, S. H.
    Lee, J. G.
    Cho, J. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E373 - E373
  • [24] Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer
    Katano, Atsuto
    Yamashita, Hideomi
    Nakagawa, Keiichi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (02)
  • [25] PSMA PET-directed surgical metastasis-directed therapy in metachronous prostate cancer
    Ambrosini, Francesca
    Koehler, Daniel
    Ghadban, Tarik
    Jacobsen, Frank
    Knipper, Sophie
    von Amsberg, Gunhild
    Steuber, Thomas
    Maurer, Tobias
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2023, 76 (03) : 182 - 185
  • [26] Outcomes of metastasis-directed treatment of bone oligometastatic disease in prostate cancer
    Rogowski, P.
    Schmidt-Hegemann, N.
    Trapp, C.
    Shi, R.
    von Bestenbostel, R.
    Ma, J.
    Belka, C.
    Li, M.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S751 - S752
  • [27] PSMA-PET GUIDED METASTASIS DIRECTED THERAPY FOR OLIGOMETASTATIC PROSTATE CANCER
    Ghaffar, Umar
    Sharma, Vidit
    Reitano, Giuseppe
    Basourakos, Spyridon P.
    Henning, Grant M.
    Ahmed, Mohamed E.
    Deol, Ekamjit S.
    Johnson, Geoffrey B.
    Andrews, Jack
    Kwon, Eugene D.
    Karnes, Robert J.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1006 - E1007
  • [28] Outcome after metastasis-directed Radiotherapy of Bone Metastases in oligometastatic Prostate Cancer
    Rogowski, P.
    Schmidt-Hegemann, N. -S.
    Trapp, C.
    Shi, R.
    von Bestenbostel, R.
    Ma, J.
    Belka, C.
    Li, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S178 - S179
  • [29] The efficacy of metastasis-directed radiation therapy (MDRT) for oligometastatic castration-resistant prostate cancer (CRPC)
    Nagahara, Akira
    Kanaki, Tomohiro
    Yamamoto, Akinaru
    Yamamoto, Yoshiyuki
    Nakai, Yasutomo
    Nakayama, Masashi
    Kakimoto, Ken-ichi
    Konishi, Koji
    Teshima, Teruki
    Nishimura, Kazuo
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [30] Metastasis-directed Therapy in Prostate Cancer: Prognostic Significance of the ESTRO/EORTC Classification in Oligometastatic Bone Disease
    Nicholls, L.
    Chapman, E.
    Khoo, V
    Suh, Y-E
    Tunariu, N.
    Wang, Y.
    van As, N.
    CLINICAL ONCOLOGY, 2022, 34 (01) : 63 - 69
12345